Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445866-13-000005
Filing Date
2013-01-03
Accepted
2013-01-03 17:21:09
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4pollack.html 4  
1 OWNERSHIP DOCUMENT form4pollack.xml 4 8961
  Complete submission text file 0001445866-13-000005.txt   10433
Mailing Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP
Business Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP 44 (0) 203 617 8739
Lightlake Therapeutics Inc. (Issuer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
SIC: 1000 Metal Mining

Mailing Address 150 RAINVILLE ROAD TARPON SPRINGS FL 34689
Business Address
Pollack Kevin (Reporting) CIK: 0001553236 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-139915 | Film No.: 13508168